Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma

Condition:   Nasopharyngeal Carcinoma Interventions:   Drug: Toripalimab;   Radiation: IMRT to the nasopharynx and neck;   Drug: Gemcitabine and Cisplatin Chemotherapy;   Drug: Adjuvant chemotherapy with Capecitabine Sponsors:   Fudan University;   Fudan University Eye and ENT Hospital;   Anhui Provincial Hospital;   Sir Run Run Shaw Hospital;   Hangzhou Cancer Hospital;   Ningbo Medical Center Lihuili Hospital;   The First People's Hospital of Changzhou;   Cancer Hospital of Chinese Academ y of Medical Science, Shenzhen Center;   Affiliated Cancer Hospital& Institute of Guangzhou Medical University;   Nanfang Hospital of Southern Medical University;   Shenzhen People's Hospital;   First Affiliated Hospital of Xi'anJiaotong Univerisity;   Guangzhou Panyu Central Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials